NMRA
NEUMORA (NMRA)
NASDAQ
$1.71-$0.04 (-2.57%)
Price as of Jun 03, 2026 6:48 PM EDT
  • $342.8M
    Market Cap
  • 135.50%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-176.1M
-12.37%
-200.9M
+40.79%
-142.7M
N/A
Depreciation and Amortization Expense
208,000
-67.04%
631,000
-5.54%
668,000
N/A
Total Operating Expenses
241.2M
-8.47%
263.5M
+4.51%
252.1M
N/A
Operating Profit
-241.2M
-8.47%
-263.5M
+4.51%
-252.1M
N/A
Interest Income
8.3M
N/A
N/A
N/A
18,000
N/A
Interest Expense
-2.0M
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
6.3M
N/A
0
-100.00%
18,000
N/A
Total Nonoperating Income and Expense
4.4M
-78.05%
19.9M
+20.77%
16.4M
N/A
Income before Taxes
-236.8M
-2.80%
-243.6M
+3.37%
-235.7M
N/A
Income Taxes
130,000
-26.97%
178,000
-33.58%
268,000
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-236.9M
-2.81%
-243.8M
+3.33%
-235.9M
N/A
Net Income from Continuing Operations Applicable to Common
-236.8M
-2.80%
-243.6M
+3.37%
-235.7M
N/A
Basic EPS and Net Income
-1.45
-5.23%
-1.53
-57.85%
-3.63
N/A
Diluted EPS and Net Income
-1.45
-5.23%
-1.53
-57.85%
-3.63
N/A
Basic Weighted Average Shares
163.4M
+2.52%
159.4M
+145.12%
65.0M
N/A
Diluted Weighted Average Shares
163.4M
+2.52%
159.4M
+145.12%
65.0M
N/A
Balance Sheet
Cash and Cash Equivalents
182.5M
+28.41%
142.1M
-62.00%
374.0M
N/A
Short-Term Investments
165.4M
0.00%
165.4M
+106.93%
79.9M
N/A
Cash and Cash Equivalents and Short-Term Investments
348.0M
+13.13%
307.6M
-32.25%
454.0M
N/A
Total Current Assets
190.5M
-39.33%
314.1M
-34.34%
478.3M
N/A
Accumulated Depreciation
187,000
-90.87%
2.0M
+42.79%
1.4M
N/A
Property and Plant and Equipment and Net
40,000
-96.49%
1.1M
-36.31%
1.8M
N/A
Total Long-Term Assets
53,000
-99.52%
11.0M
+277.10%
2.9M
N/A
Total Assets
191.0M
-39.73%
317.0M
-36.12%
496.2M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
60.0M
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
32.5M
+8.58%
29.9M
+19.02%
25.1M
N/A
Total Long-Term Debt
54.5M
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
54.7M
+2,853.32%
1.9M
0.00%
1.9M
N/A
Total Liabilities
87.2M
+191.48%
29.9M
+10.28%
27.1M
N/A
Retained Earnings
-1.2B
+25.01%
-947.2M
+34.66%
-703.4M
N/A
Total Stockholders Equity
103.9M
-63.82%
287.1M
-38.80%
469.1M
N/A
Total Shares Outstanding
174.3M
+7.76%
161.7M
+1.81%
158.8M
N/A
Cash Flow
Cash from Operating Activities
-206.4M
+12.85%
-182.9M
+12.04%
-163.3M
N/A
Capital Expenditures
N/A
N/A
117,000
0.00%
117,000
N/A
Cash from Investing Activities
168.5M
+338.84%
-70.6M
-209.58%
64.4M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
77.1M
+256.84%
21.6M
-90.69%
231.9M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-93.28%
+55.56%
-59.96%
N/A
N/A
N/A
Return on Equity
-121.21%
+87.98%
-64.48%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
5.87
-44.13%
10.51
N/A
N/A
N/A
Cash Ratio
5.62
+18.26%
4.76
N/A
N/A
N/A
Debt-to-Equity Ratio
1.10
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
0.60
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow